MAKING SCIENCE GROUP SA (ALMKS.PA) Fundamental Analysis & Valuation

EPA:ALMKS • ES0105463006

Current stock price

8.25 EUR
0 (0%)
Last:

This ALMKS.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. ALMKS.PA Profitability Analysis

1.1 Basic Checks

  • In the past year ALMKS has reported negative net income.
  • ALMKS had a positive operating cash flow in the past year.
  • In the past 5 years ALMKS reported 4 times negative net income.
  • ALMKS had a positive operating cash flow in 4 of the past 5 years.
ALMKS.PA Yearly Net Income VS EBIT VS OCF VS FCFALMKS.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 10M -10M -20M

1.2 Ratios

  • ALMKS's Return On Assets of -0.99% is on the low side compared to the rest of the industry. ALMKS is outperformed by 67.69% of its industry peers.
  • ALMKS has a worse Return On Equity (-6.62%) than 69.23% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 7.51%, ALMKS is in the better half of the industry, outperforming 69.23% of the companies in the same industry.
Industry RankSector Rank
ROA -0.99%
ROE -6.62%
ROIC 7.51%
ROA(3y)-2.49%
ROA(5y)-1.44%
ROE(3y)-23.01%
ROE(5y)-9.95%
ROIC(3y)N/A
ROIC(5y)N/A
ALMKS.PA Yearly ROA, ROE, ROICALMKS.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 50 100 150

1.3 Margins

  • ALMKS has a worse Operating Margin (1.86%) than 63.08% of its industry peers.
  • ALMKS's Operating Margin has declined in the last couple of years.
  • Looking at the Gross Margin, with a value of 20.80%, ALMKS is doing worse than 78.46% of the companies in the same industry.
  • ALMKS's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 1.86%
PM (TTM) N/A
GM 20.8%
OM growth 3YN/A
OM growth 5Y-6.4%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.93%
GM growth 5Y-5%
ALMKS.PA Yearly Profit, Operating, Gross MarginsALMKS.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 10 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. ALMKS.PA Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ALMKS is still creating some value.
  • The number of shares outstanding for ALMKS has been increased compared to 1 year ago.
  • Compared to 5 years ago, ALMKS has more shares outstanding
  • ALMKS has a better debt/assets ratio than last year.
ALMKS.PA Yearly Shares OutstandingALMKS.PA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
ALMKS.PA Yearly Total Debt VS Total AssetsALMKS.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

  • ALMKS has an Altman-Z score of 1.73. This is a bad value and indicates that ALMKS is not financially healthy and even has some risk of bankruptcy.
  • ALMKS has a Altman-Z score of 1.73. This is comparable to the rest of the industry: ALMKS outperforms 60.00% of its industry peers.
  • ALMKS has a debt to FCF ratio of 1140.00. This is a negative value and a sign of low solvency as ALMKS would need 1140.00 years to pay back of all of its debts.
  • With a Debt to FCF ratio value of 1140.00, ALMKS is not doing good in the industry: 69.23% of the companies in the same industry are doing better.
  • ALMKS has a Debt/Equity ratio of 0.46. This is a healthy value indicating a solid balance between debt and equity.
  • ALMKS's Debt to Equity ratio of 0.46 is in line compared to the rest of the industry. ALMKS outperforms 60.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF 1140
Altman-Z 1.73
ROIC/WACC1.1
WACC6.84%
ALMKS.PA Yearly LT Debt VS Equity VS FCFALMKS.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 10M -10M 20M -20M

2.3 Liquidity

  • ALMKS has a Current Ratio of 0.76. This is a bad value and indicates that ALMKS is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Current ratio of ALMKS (0.76) is worse than 72.31% of its industry peers.
  • A Quick Ratio of 0.73 indicates that ALMKS may have some problems paying its short term obligations.
  • ALMKS has a worse Quick ratio (0.73) than 66.15% of its industry peers.
Industry RankSector Rank
Current Ratio 0.76
Quick Ratio 0.73
ALMKS.PA Yearly Current Assets VS Current LiabilitesALMKS.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. ALMKS.PA Growth Analysis

3.1 Past

  • ALMKS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 61.58%, which is quite impressive.
  • Looking at the last year, ALMKS shows a quite strong growth in Revenue. The Revenue has grown by 16.22% in the last year.
  • The Revenue has been growing by 51.26% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)61.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-323.33%
Revenue 1Y (TTM)16.22%
Revenue growth 3Y35.39%
Revenue growth 5Y51.26%
Sales Q2Q%21.45%

3.2 Future

  • Based on estimates for the next years, ALMKS will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.86% on average per year.
  • The Revenue is expected to grow by 22.57% on average over the next years. This is a very strong growth
EPS Next Y-39.39%
EPS Next 2Y5.89%
EPS Next 3Y14.86%
EPS Next 5YN/A
Revenue Next Year36.31%
Revenue Next 2Y27.02%
Revenue Next 3Y22.57%
Revenue Next 5YN/A

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
ALMKS.PA Yearly Revenue VS EstimatesALMKS.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M 500M
ALMKS.PA Yearly EPS VS EstimatesALMKS.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0.1 0.2 0.3 0.4 0.5

More info and screens

Find the best growth stocksShow best growing peers

1

4. ALMKS.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for ALMKS. In the last year negative earnings were reported.
  • A Price/Forward Earnings ratio of 40.44 indicates a quite expensive valuation of ALMKS.
  • ALMKS's Price/Forward Earnings ratio is in line with the industry average.
  • When comparing the Price/Forward Earnings ratio of ALMKS to the average of the S&P500 Index (23.80), we can say ALMKS is valued expensively.
Industry RankSector Rank
PE N/A
Fwd PE 40.44
ALMKS.PA Price Earnings VS Forward Price EarningsALMKS.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40 60 80

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ALMKS is valued a bit more expensive than 60.00% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, ALMKS is valued a bit more expensive than the industry average as 69.23% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 1499.85
EV/EBITDA 9.17
ALMKS.PA Per share dataALMKS.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

  • A more expensive valuation may be justified as ALMKS's earnings are expected to grow with 14.86% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y5.89%
EPS Next 3Y14.86%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ALMKS.PA Dividend Analysis

5.1 Amount

  • No dividends for ALMKS!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ALMKS.PA Fundamentals: All Metrics, Ratios and Statistics

MAKING SCIENCE GROUP SA

EPA:ALMKS (3/18/2026, 7:00:00 PM)

8.25

0 (0%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)02-19
Earnings (Next)N/A
Inst Owners3.52%
Inst Owner ChangeN/A
Ins Owners58.8%
Ins Owner ChangeN/A
Market Cap74.99M
Revenue(TTM)274.00M
Net Income(TTM)-1.72M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-16.67%
EPS NY rev (3m)-16.67%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)1.77%
Revenue NY rev (3m)1.77%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 40.44
P/S 0.27
P/FCF 1499.85
P/OCF 227.25
P/B 2.88
P/tB N/A
EV/EBITDA 9.17
EPS(TTM)-0.2
EYN/A
EPS(NY)0.2
Fwd EY2.47%
FCF(TTM)0.01
FCFY0.07%
OCF(TTM)0.04
OCFY0.44%
SpS30.14
BVpS2.86
TBVpS-4.4
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -0.99%
ROE -6.62%
ROCE 10.22%
ROIC 7.51%
ROICexc 13.46%
ROICexgc N/A
OM 1.86%
PM (TTM) N/A
GM 20.8%
FCFM 0.02%
ROA(3y)-2.49%
ROA(5y)-1.44%
ROE(3y)-23.01%
ROE(5y)-9.95%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5Y-6.4%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.93%
GM growth 5Y-5%
F-Score6
Asset Turnover1.58
Health
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF 1140
Debt/EBITDA 1.03
Cap/Depr 4.29%
Cap/Sales 0.1%
Interest Coverage 1.14
Cash Conversion 2.84%
Profit Quality N/A
Current Ratio 0.76
Quick Ratio 0.73
Altman-Z 1.73
F-Score6
WACC6.84%
ROIC/WACC1.1
Cap/Depr(3y)13.72%
Cap/Depr(5y)311.76%
Cap/Sales(3y)0.4%
Cap/Sales(5y)7.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)61.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-323.33%
EPS Next Y-39.39%
EPS Next 2Y5.89%
EPS Next 3Y14.86%
EPS Next 5YN/A
Revenue 1Y (TTM)16.22%
Revenue growth 3Y35.39%
Revenue growth 5Y51.26%
Sales Q2Q%21.45%
Revenue Next Year36.31%
Revenue Next 2Y27.02%
Revenue Next 3Y22.57%
Revenue Next 5YN/A
EBIT growth 1Y278.77%
EBIT growth 3YN/A
EBIT growth 5Y41.58%
EBIT Next Year145.61%
EBIT Next 3Y41.06%
EBIT Next 5YN/A
FCF growth 1Y103.36%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y178.57%
OCF growth 3Y-64.23%
OCF growth 5YN/A

MAKING SCIENCE GROUP SA / ALMKS.PA Fundamental Analysis FAQ

What is the fundamental rating for ALMKS stock?

ChartMill assigns a fundamental rating of 2 / 10 to ALMKS.PA.


Can you provide the valuation status for MAKING SCIENCE GROUP SA?

ChartMill assigns a valuation rating of 1 / 10 to MAKING SCIENCE GROUP SA (ALMKS.PA). This can be considered as Overvalued.


What is the profitability of ALMKS stock?

MAKING SCIENCE GROUP SA (ALMKS.PA) has a profitability rating of 1 / 10.


What is the earnings growth outlook for MAKING SCIENCE GROUP SA?

The Earnings per Share (EPS) of MAKING SCIENCE GROUP SA (ALMKS.PA) is expected to decline by -39.39% in the next year.